YU39976B - Process for obtaining new 1-benzazolylalkyl-4-substituted piperidines - Google Patents

Process for obtaining new 1-benzazolylalkyl-4-substituted piperidines

Info

Publication number
YU39976B
YU39976B YU2480/76A YU248076A YU39976B YU 39976 B YU39976 B YU 39976B YU 2480/76 A YU2480/76 A YU 2480/76A YU 248076 A YU248076 A YU 248076A YU 39976 B YU39976 B YU 39976B
Authority
YU
Yugoslavia
Prior art keywords
benzazolylalkyl
obtaining new
substituted piperidines
piperidines
substituted
Prior art date
Application number
YU2480/76A
Other languages
English (en)
Other versions
YU248076A (en
Inventor
J Vandenberk
E J L Kennis
Aa J M C M Van Der
Th M H A Van Keertum
Original Assignee
Janssen Pharmaceutica Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Janssen Pharmaceutica Nv filed Critical Janssen Pharmaceutica Nv
Publication of YU248076A publication Critical patent/YU248076A/xx
Publication of YU39976B publication Critical patent/YU39976B/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D235/00Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings
    • C07D235/02Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings condensed with carbocyclic rings or ring systems
    • C07D235/04Benzimidazoles; Hydrogenated benzimidazoles
    • C07D235/06Benzimidazoles; Hydrogenated benzimidazoles with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 2
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/08Antiepileptics; Anticonvulsants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/20Hypnotics; Sedatives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/24Antidepressants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/26Psychostimulants, e.g. nicotine, cocaine
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D211/00Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/08Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms
    • C07D211/18Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D211/30Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by doubly bound oxygen or sulfur atoms or by two oxygen or sulfur atoms singly bound to the same carbon atom
    • C07D211/32Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by doubly bound oxygen or sulfur atoms or by two oxygen or sulfur atoms singly bound to the same carbon atom by oxygen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D235/00Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings
    • C07D235/02Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings condensed with carbocyclic rings or ring systems
    • C07D235/04Benzimidazoles; Hydrogenated benzimidazoles
    • C07D235/06Benzimidazoles; Hydrogenated benzimidazoles with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 2
    • C07D235/08Radicals containing only hydrogen and carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D235/00Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings
    • C07D235/02Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings condensed with carbocyclic rings or ring systems
    • C07D235/04Benzimidazoles; Hydrogenated benzimidazoles
    • C07D235/24Benzimidazoles; Hydrogenated benzimidazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached in position 2
    • C07D235/26Oxygen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D235/00Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings
    • C07D235/02Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings condensed with carbocyclic rings or ring systems
    • C07D235/04Benzimidazoles; Hydrogenated benzimidazoles
    • C07D235/24Benzimidazoles; Hydrogenated benzimidazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached in position 2
    • C07D235/28Sulfur atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D405/00Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/04Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
YU2480/76A 1975-10-08 1976-10-08 Process for obtaining new 1-benzazolylalkyl-4-substituted piperidines YU39976B (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US62072775A 1975-10-08 1975-10-08
US05/713,309 US4035369A (en) 1975-10-08 1976-08-10 1-Benzazolylalkyl-4-substituted-piperidines

Publications (2)

Publication Number Publication Date
YU248076A YU248076A (en) 1983-01-21
YU39976B true YU39976B (en) 1985-06-30

Family

ID=27088773

Family Applications (1)

Application Number Title Priority Date Filing Date
YU2480/76A YU39976B (en) 1975-10-08 1976-10-08 Process for obtaining new 1-benzazolylalkyl-4-substituted piperidines

Country Status (31)

Country Link
US (1) US4035369A (xx)
JP (1) JPS5246082A (xx)
AT (1) AT365185B (xx)
AU (1) AU511834B2 (xx)
BG (1) BG27542A3 (xx)
CA (1) CA1085853A (xx)
CH (1) CH630915A5 (xx)
CS (1) CS225101B2 (xx)
DE (1) DE2645125A1 (xx)
DK (1) DK151801C (xx)
EG (1) EG12969A (xx)
ES (1) ES452200A1 (xx)
FI (1) FI63228C (xx)
FR (1) FR2346009A1 (xx)
GB (1) GB1532546A (xx)
GR (1) GR61672B (xx)
HU (1) HU174927B (xx)
IE (1) IE43951B1 (xx)
IL (1) IL50631A (xx)
IT (1) IT1069293B (xx)
LU (1) LU75954A1 (xx)
NL (1) NL7611085A (xx)
NO (1) NO144926C (xx)
NZ (1) NZ182134A (xx)
PH (1) PH15417A (xx)
PL (1) PL106815B1 (xx)
PT (1) PT65688B (xx)
RO (1) RO69904A (xx)
SE (1) SE417610B (xx)
SU (1) SU663306A3 (xx)
YU (1) YU39976B (xx)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4200641A (en) * 1976-12-21 1980-04-29 Janssen Pharmaceutica, N.V. 1-[(Heterocyclyl)-alkyl]-4-diarylmethoxy piperidine derivatives
US4335127A (en) * 1979-01-08 1982-06-15 Janssen Pharmaceutica, N.V. Piperidinylalkyl quinazoline compounds, composition and method of use
IE810250L (en) * 1980-02-11 1981-08-11 Berlex Lab N-(3-phenoxy-2-hydroxypropyl) benzimidazole -1-¹alkanamines.
US4254127A (en) * 1980-04-03 1981-03-03 Janssen Pharmaceutica, N.V. 1,3-Dihydro-1-[(1-piperidinyl)alkyl]-2H-benzimidazol-2-one derivatives
DE3442757A1 (de) * 1984-11-23 1986-05-28 Wella Ag, 6100 Darmstadt Verwendung von 2-nitroanilinderivaten in haarfaerbemitteln und neue 2-nitroanilinderivate
KR930005004B1 (ko) * 1985-04-15 1993-06-11 쟈안센 파아마슈우티카 엔. 부이. 치환된 n-[(4-피페리디닐)알킬]이환 축합 옥사졸아민 및 티아졸아민의 제조방법
FR2581993B1 (fr) * 1985-05-14 1988-03-18 Synthelabo Derives de (benzoyl-4 piperidino)-2 phenyl-1 alcanols, leur preparation et leur application en therapeutique
FR2702214B1 (fr) * 1993-03-05 1995-04-14 Adir Nouveaux composés (aryl(alkyl)carbonyl)-hétérocycliques, leurs procédés de préparation et les compositions pharmaceutiques qui les contiennent.
GB9418326D0 (en) * 1994-09-12 1994-11-02 Lilly Industries Ltd Pharmaceutical compounds
ATE247114T1 (de) 1994-09-12 2003-08-15 Lilly Co Eli Serotonergische modulatoren
GB2308362A (en) * 1995-12-19 1997-06-25 Lilly Industries Ltd Pharmaceutical indole derivatives
GB9613423D0 (en) * 1996-06-26 1996-08-28 Lilly Industries Ltd Pharmaceutical compounds
WO2008035066A2 (en) * 2006-09-19 2008-03-27 Cipla Limited Processes for the preparation of ciclesonide and its crystal form
CN101759693B (zh) * 2008-12-23 2011-09-14 江苏恩华药业股份有限公司 苯骈异恶唑哌啶衍生物及在制备镇痛、镇静药物中的应用
AU2022237901A1 (en) * 2021-03-19 2023-09-28 Centre National De La Recherche Scientifique Applications of biased ligands of the serotonin 5-ht7 receptor for the treatment of pain, multiple sclerosis and the control of thermoregulation.

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE633495A (xx) * 1962-06-13
US3225052A (en) * 1964-05-06 1965-12-21 Janssen Pharmaceutica Nv Benzimidazolinyl piperidine derivatives
FR1573739A (xx) 1968-07-26 1969-07-04
US3635982A (en) * 1969-04-08 1972-01-18 American Home Prod Amino-substituted-quinoxalinyloxazolidines and -oxazines

Also Published As

Publication number Publication date
NL7611085A (nl) 1977-04-13
AU511834B2 (en) 1980-09-11
FR2346009B1 (xx) 1978-12-22
CH630915A5 (de) 1982-07-15
PH15417A (en) 1983-01-07
DK151801C (da) 1988-06-06
AU1807876A (en) 1978-04-06
PL192890A1 (pl) 1978-03-28
RO69904A (fr) 1980-08-15
IL50631A0 (en) 1976-12-31
NO144926B (no) 1981-08-31
IT1069293B (it) 1985-03-25
DE2645125C2 (xx) 1988-11-24
FR2346009A1 (fr) 1977-10-28
LU75954A1 (xx) 1977-05-09
GB1532546A (en) 1978-11-15
FI63228C (fi) 1983-05-10
NZ182134A (en) 1979-01-11
US4035369A (en) 1977-07-12
SE7611137L (sv) 1977-04-09
NO763424L (xx) 1977-04-13
PT65688A (en) 1976-11-01
ATA745276A (de) 1981-05-15
IE43951B1 (en) 1981-07-01
FI63228B (fi) 1983-01-31
JPS5246082A (en) 1977-04-12
PL106815B1 (pl) 1980-01-31
SE417610B (sv) 1981-03-30
DK452076A (da) 1977-04-09
HU174927B (hu) 1980-04-28
CA1085853A (en) 1980-09-16
ES452200A1 (es) 1978-01-16
GR61672B (en) 1978-12-05
CS225101B2 (en) 1984-02-13
SU663306A3 (ru) 1979-05-15
IE43951L (en) 1977-04-08
EG12969A (en) 1981-03-31
PT65688B (en) 1978-04-02
FI762865A (xx) 1977-04-09
JPS6215553B2 (xx) 1987-04-08
YU248076A (en) 1983-01-21
DE2645125A1 (de) 1977-04-21
BG27542A3 (en) 1979-11-12
AT365185B (de) 1981-12-28
DK151801B (da) 1988-01-04
IL50631A (en) 1980-02-29
NO144926C (no) 1981-12-09

Similar Documents

Publication Publication Date Title
YU262076A (en) Process for obtaining 2-phenyl-3-aroylbenzothiophene
HU175504B (hu) Sposob poluchenija novykh pirazinkarboksamidov
YU203476A (en) Process for obtaining new sulfonyl-benzimidazole compounds
YU140576A (en) Process for obtaining nifamycin compounds
HU175583B (hu) Sposob poluchenija novykh poligalosteroidov
HU172100B (hu) Sposob poluchenija novykh difeniloksi-proizvodnykh
HU177882B (en) Process for preparing new imidazolyl-alkyl-sulphides
YU248076A (en) Process for obtaining new 1-benzazolylalkyl-4-substituted piperidines
YU179476A (en) Process for obtaining new 1-(benzazoyl-alkyl)-piperidine derivatives
YU100676A (en) Process for obtaining piperazinylpyrazine
YU147976A (en) Process for obtaining 11-deoxy-16-aryloxy-omega-tetranoprostaglandin
CS185596B2 (en) Process for preparing new propargyl-2-phenylamino-2-imidazolines
YU233676A (en) Process for obtaining new n-aryl-n-(1-l-4-piperidinyl)-arylacetamides
HU175215B (hu) Sposob poluchenija novykh piridin-karboksamidov
GB1554153A (en) Process for making 2-amino-2-alkylthionitroethylenes
YU39352B (en) Process for obtaining new substituted benzamides
YU39771B (en) Process for preparing new homo-phthalimides
YU121176A (en) Process for obtaining rifamcin compounds
YU196776A (en) Process for obtaining phosphor-dichlorido-thiolate
HU171166B (hu) Sposob poluchenija novykh ehpoksi-androstanov
YU11476A (en) Process for obtaining 6-alkoxy-alpha-carboxy-penicillin
YU262276A (en) Process for obtaining aroyl-phenyl naphthalines
YU71576A (en) Process for preparing new oxime-ethers
YU40642B (en) Process for preparing for preparing new substituted arylalklamines
HU172553B (hu) Sposob poluchenija proizvodnykh -3-aciloksimetil-cefem- ili -3-tiometil-cefem- soedinenijj